MAICELL THERAPEUTICS

Serial Number 88848681
606

Registration Progress

Application Filed
Mar 26, 2020
Under Examination
Sep 15, 2020
Approved for Publication
Jul 21, 2020
Published for Opposition
Jul 21, 2020
Registered

Trademark Image

MAICELL THERAPEUTICS

Basic Information

Serial Number
88848681
Filing Date
March 26, 2020
Published for Opposition
July 21, 2020
Abandonment Date
October 18, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 18, 2021
Classes
042

Rights Holder

MaiCell Therapeutics, Inc.

03
Address
P.O. Box 264
Pipersville, PA 18947

Ownership History

MaiCell Therapeutics, Inc.

Original Applicant
03
Pipersville, PA

MaiCell Therapeutics, Inc.

Owner at Publication
03
Pipersville, PA

Legal Representation

Attorney
Catherine A. Cavella, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Oct 18, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 18, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 12, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 10, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 10, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 10, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 17, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 17, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 17, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 17, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 17, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 31, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 30, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of novel medical therapies for treating diabetes; Research and development in the pharmaceutical and biotechnology fields

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"